PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Clarification of recent analyst report on Patent Protection, page-12

  1. 281 Posts.
    lightbulb Created with Sketch. 107
    I would read this as saying in effect ‘yes, our patent application has been rejected, but we can appeal this decision, and we intend to do so.’

    Appeals in this area are pretty common as I understand it, but I have no idea as to the success rate.

    Things could be worse, but getting a patent application rejected on the grounds of prior art is hardly a positive.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.